Literature DB >> 23044830

Interactions between Δ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys.

Jun-Xu Li1, Wouter Koek, Charles P France.   

Abstract

The cannabinoid receptor agonist Δ(9)-tetrahydrocannabinol (THC) enhances the antinociceptive effects of µ-opioid receptor agonists, raising the possibility of using a combination of THC and opioids for treating pain. This study examined the effects of noncontingent and contingent administration of THC on intravenous heroin self-administration in rhesus monkeys. Self-administration of different unit doses of heroin (0.0001-0.1 mg/kg/infusion) generated a typical inverted U-shaped dose-response curve. In one experiment (n=4), noncontingent THC (0.1-1.0 mg/kg) dose dependently shifted the heroin dose-response curve downward in three monkeys and slightly leftward in one monkey. In a second experiment (n=4), monkeys could self-administer THC alone (0.0032-0.032 mg/kg/infusion), heroin alone, or a mixture of THC and heroin. THC alone did not maintain responding above that obtained with saline; however, increasing the THC dose with heroin dose dependently decreased the number of infusions received and the rate of responding, as compared with data that were obtained with heroin alone. These results indicate that THC does not significantly enhance the positive reinforcing effects of heroin, further supporting the view that combining cannabinoid and opioid receptor agonists (e.g. for treating pain) does not increase, and might decrease, the abuse liability of individual drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044830      PMCID: PMC3916935          DOI: 10.1097/FBP.0b013e32835a3907

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  45 in total

1.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats.

Authors:  R Galici; R N Pechnick; R E Poland; C P France
Journal:  Eur J Pharmacol       Date:  2000-01-03       Impact factor: 4.432

Review 3.  Cannabinoid receptors and pain.

Authors:  R G Pertwee
Journal:  Prog Neurobiol       Date:  2001-04       Impact factor: 11.685

Review 4.  Cannabinoids: a real prospect for pain relief?

Authors:  Leslie Iversen; Victoria Chapman
Journal:  Curr Opin Pharmacol       Date:  2002-02       Impact factor: 5.547

5.  Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.

Authors:  S R Wachtel; H de Wit
Journal:  Drug Alcohol Depend       Date:  2000-06-01       Impact factor: 4.492

6.  Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.

Authors:  M K Greenwald; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  2000-06-01       Impact factor: 4.492

7.  Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

Authors:  G Tanda; P Munzar; S R Goldberg
Journal:  Nat Neurosci       Date:  2000-11       Impact factor: 24.884

8.  Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.

Authors:  Diana L Cichewicz; Sandra P Welch
Journal:  J Pharmacol Exp Ther       Date:  2003-02-11       Impact factor: 4.030

9.  Interaction between naltrexone and oral THC in heavy marijuana smokers.

Authors:  Margaret Haney; Adam Bisaga; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

10.  Effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) and quipazine on heroin self-administration in rhesus monkeys.

Authors:  David R Maguire; Jun-Xu Li; Wouter Koek; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2012-07-27       Impact factor: 4.530

View more
  22 in total

1.  Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio.

Authors:  David R Maguire; Charles P France
Journal:  Eur J Pharmacol       Date:  2017-11-26       Impact factor: 4.432

2.  Effects of morphine/CP55940 mixtures on an impulsive choice task in rhesus monkeys.

Authors:  Vanessa Minervini; Charles P France
Journal:  Behav Pharmacol       Date:  2018-02       Impact factor: 2.293

3.  Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures.

Authors:  David R Maguire; Charles P France
Journal:  Drug Alcohol Depend       Date:  2020-05-12       Impact factor: 4.492

4.  Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.

Authors:  David R Maguire; Wenjuan Yang; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2013-03-27       Impact factor: 4.030

5.  Effect of footshock stress on place conditioning produced by Δ9-tetrahydrocannabinol and the fatty acid amide hydrolase (FAAH) inhibitor, URB597, in Sprague-Dawley rats.

Authors:  Marieka V DeVuono; Kiri L Wills; Danielle V MacPherson; Kelly M Hrelja; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2017-08-12       Impact factor: 4.530

6.  Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys.

Authors:  Lisa R Gerak; Peter F Weed; David R Maguire; Charles P France
Journal:  Drug Alcohol Depend       Date:  2019-06-29       Impact factor: 4.492

Review 7.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

8.  Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.

Authors:  David R Maguire; Charles P France
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

9.  Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.

Authors:  Ziva D Cooper; Gillinder Bedi; Divya Ramesh; Rebecca Balter; Sandra D Comer; Margaret Haney
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

10.  Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.

Authors:  David R Maguire; Charles P France
Journal:  Eur J Pharmacol       Date:  2016-05-13       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.